Announcement by the ESP2 study team
We have decided to suspend ESP2 on 30th April 2022 and to review whether to start again in one year’s time. The pandemic has changed many things, including how trials are run so we want to let things settle and understand the changes before we decide whether to start again in 2023. Thank you for your interest and support of ESP2 so far, we hope to return.
Find out more here: https://w3.abdn.ac.uk/hsru/ESP2/
Are you setting up new trial recruitment sites?
Thousands of trials are conducted every year, and all of them require recruiting participants. Setting up trial sites to support this recruitment takes time, effort and money. Despite all this, not all trial sites go on to recruit as hoped. What would help is a way to predict whether a site would be a “good” recruitment site.
The Estimating Site Performance–2 project (ESP2) aims to test a tool that might help. The project aims to include experiences from across the globe, which will ensure that the findings and recommendations that follow are globally relevant.
The tool being tested is a checklist that asks the person who has just set up a trial recruitment site to consider eight ‘red flags’ for recruitment (e.g. lack of site staff engagement, or previous poor performance) and then make a prediction as to whether the site will hit its recruitment target or not. The flags were developed in a project published in Trials in 2019: https://doi.org/10.1186/s13063-019-3287-6.
ESP2 needs 1000 recruitment predictions. Predictions are recorded using a web-based system at https://w3.abdn.ac.uk/hsru/ESP2/. After a prediction has been made, the ESP2 system will contact you again six months later and then again at 12 months to see how recruitment is going.
At the end of the project, we will have tested a simple, evidence-based tool for predicting site recruitment success. Having such a tool would mean that we could make informed decisions about how much effort to devote to individual sites, or whether to look for alternative sites. The intention is to stop using resources on sites that we know are highly unlikely to recruit. Additionally, if we get predictions from around the world, we will be able to say whether there are differences depending on where predictions are made, or whether we have, in fact, got a globally applicable trial recruitment prediction tool.
You can find out more about ESP2 and sign up at:
https://w3.abdn.ac.uk/hsru/ESP2/
